Teladoc Health
TDOC
365 hedge funds and large institutions have $1.15B invested in Teladoc Health in 2024 Q3 according to their latest regulatory filings, with 58 funds opening new positions, 85 increasing their positions, 130 reducing their positions, and 95 closing their positions.
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
26% more call options, than puts
Call options by funds: $60.8M | Put options by funds: $48.2M
8.59% less ownership
Funds ownership: 81.93% → 73.33% (-8.6%)
10% less funds holding
Funds holding: 405 → 365 (-40)
15% less capital invested
Capital invested by funds: $1.36B → $1.15B (-$207M)
35% less repeat investments, than reductions
Existing positions increased: 85 | Existing positions reduced: 130
39% less first-time investments, than exits
New positions opened: 58 | Existing positions closed: 95
Top Buyers
Top Sellers
| 1 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
-$61.9M |
| 2 |
NAMA
Nikko Asset Management Americas
New York
|
-$40.5M |
| 3 |
Sumitomo Mitsui Trust Group
Minato-Ku, Tokyo,
Japan
|
-$40.5M |
| 4 |
CC
Clearline Capital
New York
|
-$31.8M |
| 5 |
BlackRock
New York
|
-$28M |
TDOC Hedge Fund Activity: Q3 2024 in Review
365 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Teladoc Health (TDOC) for Q3 2024, worth a combined $1.15B — down 15% from $1.36B a quarter earlier.
Sellers outnumbered buyers: 95 funds closed out of TDOC and 58 opened new positions — a net loss of 37 holders — while 130 trimmed existing stakes and 85 added.
The largest buyer was Goldman Sachs, adding an estimated $45M. The largest seller was ARK Investment Management, exiting entirely with an estimated $61.9M sold.
- 365 institutional investors held Teladoc Health (TDOC) as of Q3 2024, down from 405 in Q2 2024.
- Funds reported $1.15B of Teladoc Health stock for Q3 2024, down 15% quarter-over-quarter.
- 58 funds opened new Teladoc Health positions in Q3 2024 and 95 closed out, a net change of -37 holders.
- The largest Teladoc Health buyer in Q3 2024 was Goldman Sachs, an estimated $45M added.
- The largest Teladoc Health seller in Q3 2024 was ARK Investment Management, an estimated $61.9M sold.
Based on aggregated 13F filings for Q3 2024.